C10009544 / invoice 10000
Species:CANINE
Breed:Greyhound Cross
Age (years):12
Diagnosis or signs:Checkup
Consult notes
10/03/2026 Rectal temp 38.2C No vomiting. Pink mucosa. Mucosa a bit dry and sticky but not panting. Diarrhoea managed. Concern about prune pit consumed. Could it cause a blockage? Femoral pulses strong. HR 58bpm.
Animal clinical history (3 most recent)
2026-03-10T00:00:00Z 13:58:12
Rectal temp 38.2C No vomiting. Pink mucosa. Mucosa a bit dry and sticky but not panting. Diarrhoea managed. Concern about prune pit consumed. Could it cause a blockage? Femoral pulses strong. HR 58bpm.
2026-02-23T00:00:00Z 16:20:28
Referral Letter for Billie Silva Patient Details: Name: Billie Description: Age: Female Desexed Black With White Greyhound Cross 12 Years Owner: Ms Jules Silva 195 Wood Sreet, Preston Victoria 3072 - 0407661994 Date: February 16, 2026 Thanks for the referral of Billie Silva. Please find details of Billie's recent visit to our practice below. Notes: 23/02/2026 Diagnosis: Multicentric B cell lymphoma, stage III+ (poss stage V atypical circulating lymphs), substage a diagnosed 10/12/25 Chemotherapy protocol: CHOP Response to treatment: strong partial/complete remission Treatment due: Doxorubicin Treatment number: 8/16 Side effects last chemo: none Protocol modifications: - monitor diarrhoea secondary to vincristine -15% dose reduction doxorubicin due to grade 2 diarrhoea and grade 1 hyporexia Restaging/monitoring plan: Monitor PLN, perform FBE, chemistry + urinalysis today and 16th treatment Other medical history/co-morbidities: - Atopy (grass allergy) – desensitisation therapy MVSC derm 2017/18 minimal response per O, responds well to cytopoint (not currently receiving) History since last visit: Billie has been very well at home, EDDU normally. There are no new concerns. Current diet: dry food, cooked egg, sardines/tuna Current medications: - Prokolin, smectite and ondansetron following GI AEs, none since 26/1 Physical Examination findings: Demeanour: BAR Body condition score 5/9 good MM pink, CRT< 2 secs, HR 128, RR 32, Temp 38.6C Wt: 26.6kg BSA: 0.9m2 Oral: brief exam no major concerns Eyes: no concerns noted Ears: no concerns noted Nose: no concerns noted Integument: Haired firm cutaneous mass approx 5-6mm R tarsal region, unchanged. Firm SQ mass over L hip (likely has been present but not noted earlier) approx 10mm. Soft SQ mobile mass L ventrolateral abdomen (new) Lymph nodes: lymph nodes largely palpate normally , for reference: - L SMLN 9mm prominent, R SMLN 10mm prominent - still palpate firmer/not normal - L + R PSLN <10mm max diameter palpably normal - L pop 8mm; R pop 9mm normal Inguinal and axillary not palpable Attempted aspirate of mandibular LNs - R side largely fat + blood. L side scant lymphoid tissue obtained. Cardiovascular: no murmur on auscultation, pulses strong and synchronous Respiratory: normal bronchovesicular sounds bilaterally, normal rate and effort Abdomen: no fluid or masses on palpation, soft and comfortable Rectal: no internal lymphadenopathy, soft stool on glove Musculoskeletal: ambulatory x 4, normal gait, full MSK exam not performed Neurological: no abnormalities noted, full neurological exam not performed Laboratory: Hct: 0.422 WCC: 4.34 Neuts: 2.53 Platelets: 305 Manual assessment: neutrophils 71%, monocytes 6%, lymphocytes 19% eosinophil: 4% Platelets: clumped and adequate Morphology: normal Pathologist blood smear review to assess for atypical circulating cells. Chemistry unremarkable Urinalysis pending. Aspirates of L + R mandibular nodes. Non-diagnostic R side. Scant lymphoid tissue L side but clear mixed population of small and int lymphs, not consistent with lymphoma. Assessment: - Multicentric B cell lymphoma, stage V substage a - complete remission (pending FBE results) - Grade 1 neutropenia - OK for chemotherapy Treatment: Doxorubicin 25.5mg/m2 (15% dose reduction) = 22.9mg (11.4mL) administered slow IV over 20 minutes with saline in the right cephalic vein. At home medications: - Maropitant 60mg PO SID next 4 days starting today - Ondansetron 16mg PO BID-TID PRN nausea - if diarrhoea develops, smectite 4.3g PO TID (1 1/3rd sachet Diarrh-relieve) Client communication: We are very pleased that Billie appears to be in a complete remission. We discussed the dose reduction of doxorubicin today to reduce the risk of severe diarrhoea and hyporexia, and advised on prophylactic medications. We also advised that limited lymphoid sample was obtained today but what was visible indicated reactive/normal LNs. Further, typically neoplastic LNs readily shed neoplastic cells, meaning a reactive process is even more likely. Billie's owner was very happy with the results and plan. Next visit: 2/3/26 for CBC nadir Next chemotherapy visit: due 9/3/26 however due to PH will need to be delayed until 10/3/26 for CBC + vincristine
2026-02-16T00:00:00Z 15:20:01
Referral Letter for Billie Silva Patient Details: Name: Billie Description: Age: Female Desexed Black With White Greyhound Cross 12 Years Owner: Ms Jules Silva 195 Wood Sreet, Preston Victoria 3072 - 0407661994 Date: February 16, 2026 Thanks for the referral of Billie Silva. Please find details of Billie's recent visit to our practice below. Notes: 16/02/2026 Diagnosis: Multicentric B cell lymphoma, stage III+ (poss stage V atypical circulating lymphs), substage a diagnosed 10/12/25 Chemotherapy protocol: CHOP Response to treatment: strong partial/complete remission Treatment due: vincristine Treatment number: 7/16 Side effects last chemo: none Protocol modifications: - monitor diarrhoea secondary to vincristine - 10% dose reduction doxorubicin due to grade 2 diarrhoea and grade 1 hyporexia Restaging/monitoring plan: Monitor PLN, perform FBE, chemistry + urinalysis 8th and 16th treatments Other medical history/co-morbidities: - Atopy (grass allergy) – desensitisation therapy MVSC derm 2017/18 minimal response per O, responds well to cytopoint (not currently receiving) History since last visit: Billie has been very well at home, EDDU normally. There are no new concerns. Current diet: dry food, cooked egg, sardines/tuna Current medications: - Prokolin, smectite and ondansetron following GI AEs, none since 26/1 Physical Examination findings: Demeanour: BAR Body condition score 5/9 good MM pink, CRT< 2 secs, HR 128, RR 40 (anxious), Temp 38.1C Wt: 25.5kg BSA: 0.875m2 Oral: brief exam no major concerns Eyes: no concerns noted Ears: no concerns noted Nose: no concerns noted Integument: Haired firm cutaneous mass approx 5-6mm R tarsal region, unchanged. Firm SQ mass over L hip (likely has been present but not noted earlier) approx 10mm. Lymph nodes: lymph nodes largely palpate normally , for reference: - L SMLN 9mm prominent, R SMLN 10mm prominent - still palpate firmer/not normal - plan to sample next visit INI - L + R PSLN <10mm max diameter palpably normal - L pop 8mm; R pop 9mm normal Inguinal and axillary not palpable Cardiovascular: no murmur on auscultation, pulses strong and synchronous Respiratory: normal bronchovesicular sounds bilaterally, normal rate and effort Abdomen: no fluid or masses on palpation, soft and comfortable Rectal: NE Musculoskeletal: ambulatory x 4, normal gait, full MSK exam not performed Neurological: no abnormalities noted, full neurological exam not performed Laboratory: Hct: 0.43 WCC: 8.11 Neuts: 5.73 Platelets: 339 Manual assessment: neutrophils 77%, monocytes 4%, lymphocytes 7% eosinophil: 12% Platelets: clumped and adequate Morphology: normal Assessment: - Multicentric B cell lymphoma, stage V substage a - strong partial/complete remission - OK for chemotherapy Treatment: Vincristine 0.67mg/m2 (rounded down, same dose as prev) = 0.59mg (0.59mL) administered IV in the left cephalic vein. At home medications: - Ondansetron 16mg PO BID-TID PRN nausea - if diarrhoea develops, smectite 4.3g PO TID (1 1/3rd sachet Diarrh-relieve) Client communication: We discussed how pleased we were Billie is tolerating treatment well. Given Billie's mandibular LNs remain prominent, we will sample these next week (halfway point) to ensure they are just reactive and do not contain lymphoma. We will see Billie in 1 week for her next chemotherapy treatment Next chemotherapy visit: 23/2/26 for CBC + chemistry + urinalysis +/- SMLN sampling + doxorubicin if all going well
Previous claim history (6)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-01-05 | C09709810 | LYMPHOMA (MALIGNANT) |
| 2025-12-29 | C09683009 | LYMPHOMA (MALIGNANT) |
| 2025-12-12 | C09618828 | LYMPHADENOPATHY |
| 2025-12-10 | C09606167 | MASS LESION - SKIN (CUTANEOUS) |
| 2025-12-10 | C09606167 | ANAL SAC IMPACTION |
| 2025-12-03 | C09578935 | LYMPHADENOPATHY |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation | 104.00 | 2026-03-10 | — |
UPM+
- DG02636LYMPHOMA (MALIGNANT)DSTP_lymphoma
Variant (sleepy_king)
LYMPHOMA (MALIGNANT)
DSTP_lymphoma
Conf: 0.800
Threshold: 0.19
Above: ✓
Correct?